Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cefepime × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

pembrolizumab 1118 Specimen Handling 794 Carboplatin 735 Magnetic Resonance Spectroscopy 717 Cyclophosphamide 711 Cisplatin 632 Nivolumab 623 Paclitaxel 554 Radiotherapy 528 Gemcitabine 490 Biopsy 481 Bevacizumab 420 Dexamethasone 399 Docetaxel 349 fludarabine 349 venetoclax 341 atezolizumab 326 Fluorouracil 325 Oxaliplatin 323 Capecitabine 319 Rituximab 311 durvalumab 300 Drug Therapy 296 Radiosurgery 283 Doxorubicin 279 Standard of Care 276 Pemetrexed 274 Ipilimumab 272 Blood Specimen Collection 271 Radiation 257

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡